ARISE Plus carried out a further workshop to finalise ASEAN Pharmaceutical Regulatory Framework (APRF) on 21 June 2022 to address the last remaining issues from the previous workshop held on 7th March 2022.
The ASEAN experts representing the Pharmaceutical Product Working Group (PPWG) and the ASEAN Health Cluster 3 (AHC 3) successfully resolved all outstanding concerns and agreement was reached that the version developed during the workshop should be forwarded for endorsement by the AHC 3 and PPWG.
For more details please visit: News on ASEAN Pharmaceuticak Regulatory Framework (APRF)
